BAVA:VIE
Bavarian Nordic
28,96 €
arrow_downward
-0,55%(-0,16) 1G
2 ott, 17:36:00 GMT+2 · EUR
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per BAVA in corso…
Apertura
28,46 €
Massimo
28,98 €
Minimo
28,46 €
Cap. mercato
2,59 Mld
Vol. medio
65,00
Volume
0,00
Max 52 sett.
32,47 €
Min 52 sett.
22,96 €
N. di dipendenti
2K
Apertura
28,46 €
Massimo
28,98 €
Minimo
28,46 €
Cap. mercato
2,59 Mld
Vol. medio
65,00
Volume
0,00
Max 52 sett.
32,47 €
Min 52 sett.
22,96 €
N. di dipendenti
2K
Articoli giornalistici
Da fonti web e partner giornalistici
Invezz
·
2 giorni fa
Dow +260 punti: dati sull'occupazione deboli spingono i titoli USA
Dove Investire
·
10 ore fa
Wall Street entra nel quarto trimestre con Treasury al 5,3%: cosa può fermare l’S&P 500?
Milano Finanza
·
2 giorni fa
*Wall Street: metà seduta, Dow Jones in rialzo dello 0,33%
Vietnam.vn
·
1 giorno fa
Una settimana dai risultati altalenanti a Wall Street.
Profilo
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Informazioni su Bavarian Nordic